Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prevalence and frequency of haematological testing in patients initiating clozapine in the USA.

BMJ mental healthยท2026
Same author

C-Reactive Protein/Albumin Ratio (CAR)-Integrated IMDC Model Improves Risk Stratification in Metastatic Renal Cell Carcinoma.

Cancersยท2026
Same author

Risk of Fetal Exposure to Teratogenic Medications: Development of Evidence for the Teratogenic Risk Impact and Mitigation (TRIM) Tool.

Drug safetyยท2026
Same author

How variant discovery redefines genetic prevalence: the case of cystine stone disease.

European journal of human genetics : EJHGยท2026
Same author

Intentional pediatric nonprescription cold/cough and analgesic/antipyretic exposure trends amid the COVID-19 pandemic.

Clinical toxicology (Philadelphia, Pa.)ยท2026
Same author

A Bayesian Framework for the Network Analysis of Transmission Dynamics in Infectious Disease.

Journal of molecular evolutionยท2026

Related Experiment Video

Updated: Jul 4, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Radiotherapy and survival in prostate cancer patients: a population-based study.

Esther H Zhou1, Rodney J Ellis, Edward Cherullo

  • 1Department of Urology, Case Western Reserve University School of Medicine, Cleveland, OH, USA.

International Journal of Radiation Oncology, Biology, Physics
|June 10, 2008
PubMed
Summary

Radical prostatectomy (RP) and brachytherapy (BT) significantly improve prostate cancer survival rates compared to no treatment (NT). This population-based study highlights the benefits of definitive therapies for better patient outcomes.

More Related Videos

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Related Experiment Videos

Last Updated: Jul 4, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Area of Science:

  • Oncology
  • Urology
  • Geriatric Medicine

Background:

  • Prostate cancer (CaP) is a significant health concern in older men.
  • Standard treatment options include radical prostatectomy (RP), brachytherapy (BT), external beam radiotherapy, androgen deprivation therapy, and no treatment (NT).
  • Understanding the comparative survival outcomes of these modalities is crucial for clinical decision-making.

Purpose of the Study:

  • To evaluate the association between five standard prostate cancer treatment modalities and overall/disease-specific survival.
  • To compare the effectiveness of RP, BT, external beam radiotherapy, androgen deprivation therapy, and no treatment (NT) in older men with CaP.

Main Methods:

  • Analysis of 10,179 men aged 65+ with incident prostate cancer diagnosed between 1999-2001.
  • Utilized linked Ohio Cancer Incidence Surveillance System, Medicare, and death certificate data.
  • Employed Cox multiple regression models to analyze survival through 2005, controlling for relevant patient factors.

Main Results:

  • Disease-specific survival at 7 years was 92.3% for localized and 23.9% for distant prostate cancer.
  • RP and BT were associated with a significantly reduced risk of CaP-specific death compared to NT.
  • For localized disease, RP and BT monotherapy showed hazard ratios of 0.25 and 0.45, respectively, versus NT.

Conclusions:

  • Radical prostatectomy (RP) and brachytherapy (BT) are linked to improved survival in prostate cancer patients.
  • Further research is needed to refine patient selection for definitive therapy versus conservative management.
  • Improved predictive modeling can aid in tailoring prostate cancer treatment strategies.